Accessorized Pre-Filled Syringe to Autoinjector Pharmacokinetic Bridging Study in Anifrolumab

Trial Identifier:	D3465C00002
Sponsor:	AstraZeneca
Collaborator:	Parexel International
NCTID::	NCT05339100
Start Date:	March 2022
Primary Completion Date:	April 2023
Study Completion Date:	April 2023

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version
	German (Germany) Translation
	English (UK) Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
DE	Berlin, DE, 14050
GB	Harrow, GB, HA1 3UJ
US, MD	Brooklyn, MD, US, 21225

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.